Mannkind stock falls after announcing stock offering

You are here: Home > Central Coast Health Watch > Current Article

Mannkind stock falls after announcing stock offering

By Staff Report / Thursday, March 1st, 2018 / Comments Off on Mannkind stock falls after announcing stock offering

Mannkind reported $4.5 million in revenue for the fourth quarter and $11.75 million for the full year, significantly increasing product sales revenue while it transitions away from its former collaboration with Sanofi. Shares fell more than 5 percent to $2.78 as of noon on Feb. 28 after the company announced another stock offering, raising $50…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.